EGFR and hepatocellular carcinoma: It was shown that hypoxia-specific downregulates YTHDF2 expression in HCC cells and YTHDF2 binding to the m6A site modified by EGFR 3′-UTR promotes EGFR mRNA degradation in HCC cells and inhibits proliferation of HCC cells (Zhong et al., 2019).